Euglycemic diabetic ketoacidosis associated with a sodium-glucose co transporter 2 inhibitor use in a trauma patient: a case report
SGLT2i use is associated with a significantly increased risk of EDKA. Early diagnosis is critical due to its potential lethal consequences. Reintroducing SGLT2i in ICU patients, especially trauma patients at high sepsis risk, requires careful, daily reassessment given their unpredictable clinical course.
Authors
- Myriam Lamamri (ORCID: https://orcid.org/0000-0002-2810-443X)
- Emmanuel Weiss (ORCID: https://orcid.org/0000-0002-2854-9607)
- Julie Dupont
- Ophélie Dirand
Institutions
- Inserm (FR)
- Université Paris Cité (FR)
- Hôpital Beaujon (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Centre de Recherche sur l'Inflammation (FR)
Publication Details
- Journal
- International Journal of Emergency Medicine
- Published
- 2025-08-12
- DOI
- https://doi.org/10.1186/s12245-025-00963-8
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00